XOMAP
HEALTHCAREXOMA Corp
$25.32-0.07 (-0.26%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving XOMAP Today?
No stock-specific AI insight has been generated for XOMAP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$23.34$28.22
$25.32
Fundamentals
Market Cap—
P/E Ratio25.3
EPS$1.00
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.6%
Debt / Equity—
Trading
Volume693
Avg Volume (10D)—
Shares Outstanding—
XOMAP News
25 articles- XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law FirmGlobeNewswire Inc.·Apr 28, 2026
- Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their ShareholdersGlobeNewswire Inc.·Apr 28, 2026
- Royalty Powerhouse: Ligand And Xoma Unite In $739 Million DealYahoo Finance·Apr 27, 2026
- Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 MillionBenzinga·Apr 27, 2026
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of XOMA Royalty Corporation (NASDAQ: XOMA)GlobeNewswire Inc.·Apr 27, 2026
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Miluna Acquisition Corp. (NASDAQ: MMTX)GlobeNewswire Inc.·Apr 27, 2026
- Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty AggregatorYahoo Finance·Apr 27, 2026
- We Believe XOMA Royalty's (NASDAQ:XOMA) Earnings Are A Poor Guide For Its ProfitabilityYahoo Finance·Mar 26, 2026
- XOMA Royalty Q4 Earnings Call HighlightsMarketbeat·Mar 18, 2026
- XOMA Royalty Declares Quarterly Preferred Stock DividendsYahoo Finance·Mar 18, 2026
- XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business AchievementsYahoo Finance·Mar 18, 2026
- XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026Yahoo Finance·Mar 12, 2026
- XOMA Royalty to Present at Investor Conferences in MarchYahoo Finance·Feb 18, 2026
- XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.Yahoo Finance·Feb 9, 2026
- Institutional owners may take dramatic actions as XOMA Royalty Corporation's (NASDAQ:XOMA) recent 12% drop adds to one-year lossesYahoo Finance·Jan 18, 2026
- XOMA Royalty Announces CFO TransitionYahoo Finance·Jan 12, 2026
- XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for MezagitamabYahoo Finance·Dec 30, 2025
- XOMA Royalty (NASDAQ:XOMA) shareholders have earned a 13% CAGR over the last three yearsYahoo Finance·Dec 21, 2025
- XOMA Royalty Enters into Agreement to Acquire Generation BioYahoo Finance·Dec 15, 2025
- Huge Insider Buying in MGM and Salesforce247 Wall St·Dec 12, 2025
- Xoma Crumbles And Partner Rezolute Collapses On Failed Insulin Disease DrugYahoo Finance·Dec 11, 2025
- XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plcYahoo Finance·Dec 5, 2025
- Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of AcquisitionYahoo Finance·Dec 5, 2025
- Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA RoyaltyYahoo Finance·Nov 26, 2025
- XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.Yahoo Finance·Nov 21, 2025
All 25 articles loaded
Price Data
Open$25.41
Previous Close$25.38
Day High$25.41
Day Low$25.38
52 Week High$28.22
52 Week Low$23.34
52-Week Range
$23.34$28.22
$25.32
Fundamentals
Market Cap—
P/E Ratio25.3
EPS$1.00
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.6%
Debt / Equity—
Trading
Volume693
Avg Volume (10D)—
Shares Outstanding—
About XOMA Corp
XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—